Accredited CPD activity for General Practitioners on biosimilar medicines

Accredited CPD Activity for General Practitioners

This activity addresses the following learning objectives using a combination of reading and active listening to video content:

Upon completion of this activity, participants will be able to:

EXPERTISE	Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines
PATIENT CARE	Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product Manage patient concerns and queries surrounding biosimilar medicines
PRACTICE	Define the criteria that must be met in order to substitute a PBS-subsidised reference biological for a biosimilar medicine

This activity has been approved for two (2) CPD Activity points in the RACGP CPD 2020-2022 triennium.

Accreditation number: 187138.